ONCY
Oncolytics Biotech
ONCY
ONCY
36 hedge funds and large institutions have $1.46M invested in Oncolytics Biotech in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $1.56M → $1.46M (-$98.7K)
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$111K | |
| 2 | +$110K | |
| 3 | +$29.7K | |
| 4 |
Renaissance Technologies
New York
|
+$23.1K |
| 5 |
JP Morgan Chase
New York
|
+$20.5K |
Top Sellers
| 1 | -$78K | |
| 2 | -$64.2K | |
| 3 | -$56K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$47.4K |
| 5 |
Two Sigma Advisers
New York
|
-$44.2K |